D2 Dopamine Receptor and Genes and Associated United States Patents

Case ID:
Web Published:

Technology Overview

Researchers at OHSU have cloned the D2 Dopamine receptor, and have developed cell lines containing both the D2 short and long forms, which are useful in studying ligand-receptor interactions, and developing potential drug candidates for treatment of neurological diseases. Currently, the university holds numerous patents covering the gene and protein sequences encoding for this receptor and its use as a target for drug development purposes, as well as methods for preparing labeled or unlabeled species for research and development.

Dopamine receptors have key roles in many processes, including the control of motivation, addiction and fine motor movement, as well as modulation of neuroendocrine signaling. Abnormal dopamine receptor signaling in the central nervous system is implicated in several neuropsychiatric disorders, including Tourette's syndrome, Parkinson's disease, schizophrenia, Attention-deficit hyperactivity disorder, and drug and alcohol dependence. Thus, dopamine receptors are common drug targets for  antipsychotics and psychostimulants.


Licensing Opportunity

The D2 short form and D2 long form of the receptor are available for non-exclusive licensing as stable transfectants in HEK cells. They are functional in cAMP assays looking at the inhibition of FSK stimulation.  The receptor is tagged with an M1 Flag epitope and, using antibodies to the epitope, show high levels of expression in immunoflourescence characterization.


This technology ID # 0165 covers all uses of the Dopamine D2 receptor under US patents.


Selected Publications

Grandy DK, Marchionni MA, Makam H, Stofko RE, Alfano M, Frothingham L, Fischer JB, Burke-Howie KJ, Bunzow JR, Server AC, et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc Natl Acad Sci. 1989 Dec.86(24):9762-6. 

Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M, Machida CA, Neve KA, Civelli O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 1988 Dec 22-29;336(6201):783-7.


Patent Information:
Research Tools
For Information, Contact:
Trina Voss
Technology Development Manager
Oregon Health & Science University
Olivier Civelli
James Bunzow
David Grandy
Curtis Machida
Biological Materials
Biological Materials - Receptors/Targets
Research Tools
Research Tools - Screening
© 2021. All Rights Reserved. Powered by Inteum